FDA Adverse Event Injury Summary report: N

ENDOTAK RELIANCE

MDR report key: 3052762 · Received April 11, 2013

Report

Report Number
2124215-2013-04939
Event Type
Injury
Date Received
April 11, 2013
Date of Event
February 27, 2013
Report Date
April 1, 2013
Manufacturer
CPI - DEL CARIBE
Product Code
NVY
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

UPON RECEIPT AT OUR POST MARKET QUALITY ASSURANCE LABORATORY, THE LEAD WAS THOROUGHLY ANALYZED. VISUAL INSPECTION OF THE LEAD NOTED BOTH THE INTERNAL AND THE EXTERNAL INSULATION WAS ABRADED THROUGH TO THE CONDUCTOR COIL. MICROSCOPIC EVALUATION INDICATED THAT THE INSULATION DAMAGE WAS CAUSED BY LOCALIZED COMPRESSIVE STRESS ON THE INSULATION SURFACE. DUE TO THE LOCATION AND THE TYPE OF DAMAGE EXHIBITED, IT WAS CONCLUDED THAT THIS DAMAGE WAS CAUSED BY LEAD ENTRAPMENT IN THE CLAVICLE-FIRST RIB REGION. IN ADDITION, THE HIGH VOLTAGE CABLES WERE FOUND LOOPED OUT OF THE INSULATION; HOWEVER, THIS DAMAGE IS CONSISTENT WITH PULLING ON THE LEAD WITH FORCE DURING THE EXPLANT PROCEDURE. LABORATORY ANALYSIS CONFIRMED THAT THE LEAD DAMAGE DUE TO ENTRAPMENT IN THE CLAVICLE FIRST RIB REGION MOST LIKELY CONTRIBUTED TO THE CLINICAL OBSERVATIONS OF NOISE, OVERSENSING AND INAPPROPRIATE THERAPY.

Additional Manufacturer Narrative · 1

THE PRODUCT IS EXPECTED TO BE RETURNED FOR ANALYSIS. THIS REPORT WILL BE UPDATED UPON RETURN AND COMPLETION OF ANALYSIS.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS RIGHT VENTRICULAR (RV) LEAD WAS OVERSENSING NOISE WHICH THEN RESULTED IN THE DELIVERY OF INAPPROPRIATE ANTI-TACHYCARDIA PACING (ATP). THE NOISE COULD BE REPRODUCED WITH EXERCISE. IN ADDITION, LOW SENSING MEASUREMENTS WERE ALSO NOTED. A REVISION WAS PERFORMED AND THIS LEAD WAS EXPLANTED AND SUCCESSFULLY REPLACED. ONCE THE LEAD WAS EXPLANTED, THE PHYSICIAN NOTED AN INSULATION BREACH AND THE EXTERNALIZATION OF THE CONDUCTOR COILS UNDER THE SUTURE SLEEVE. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

Description of Event or Problem · 1

---

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
155596 ENDOTAK RELIANCE IMPLANTABLE LEAD NVY CPI - DEL CARIBE 0174

Patients

Seq Age Sex Outcome Treatment
1 Hospitalization| L| R 0175| T175| F141| 0174